PHARMACOKINETICS OF FLUCONAZOLE IN CATS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION

被引:17
作者
CRAIG, AJ [1 ]
RAMZAN, I [1 ]
MALIK, R [1 ]
机构
[1] UNIV SYDNEY,DEPT PHARM,SYDNEY,NSW 2006,AUSTRALIA
关键词
D O I
10.1016/0034-5288(94)90133-3
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Fluconazole (100 mg) was administered to six adult cats as an intravenous infusion over 30 minutes, and the same cats received 100 mg of the drug orally 16 weeks later. The cats were bled repeatedly through an indwelling jugular catheter, the plasma fluconazole concentrations were assayed by high performance liquid chromatography, and the concentration-time data were subjected to a non-compartmental pharmacokinetic analysis. The mean (SD) intravenous half-life (13.8 [2.6] hours) was similar to that observed after oral dosing (12.4 [3.0] hours). The plasma clearances (intravenous 0.9 [0.1], oral 0.9 [0.2] mi min(-1) kg(-1)) and the volumes of distribution at steady state (intravenous 1.1 [0.1], oral 1.0 [0.1] litre kg(-1)) were also similar after the two routes of dosing. The peak plasma concentration was reached 2.6 hours after oral dosing and the drug was completely bioavailable (1.09 [0.05]). On the basis of this single dose study, the administration of 50 mg fluconazole every eight hours to a 4 kg cat should produce average steady state plasma fluconazole concentrations of approximately 33 mg litre(-1).
引用
收藏
页码:372 / 376
页数:5
相关论文
共 15 条
[1]  
ALTMAN P, 1974, BIOL DATA BOOK, P1999
[2]   FLUCONAZOLE PENETRATION INTO CEREBROSPINAL-FLUID - IMPLICATIONS FOR TREATING FUNGAL-INFECTIONS OF THE CENTRAL NERVOUS-SYSTEM [J].
ARNDT, CAS ;
WALSH, TJ ;
MCCULLY, CL ;
BALIS, FM ;
PIZZO, PA ;
POPLACK, DG .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (01) :178-180
[3]  
BODEY GP, 1992, CLIN INFECT DIS S1, V14, P161
[4]  
CHEW DJ, 1989, CAT DISEASES CLIN MA, P56
[5]  
GILBALDI M, 1982, PHARMACOKINETICS, P445
[6]   FLUCONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL AND SYSTEMIC MYCOSES [J].
GRANT, SM ;
CLISSOLD, SP .
DRUGS, 1990, 39 (06) :877-916
[7]  
HUMPHREY MJ, 1985, ANTIMICROB AGENTS CH, V28, P649
[8]  
MALIK R, 1992, J MED VET MYCOL, V30, P133
[9]  
MEDLEAU L, 1990, AM J VET RES, V51, P1454
[10]  
Medleau L., 1990, INFECT DIS DOG CAT, P687